CLINICAL_TRIALS
trial_result
· 2020-12-03
Clinical Trial Update: Seprafilm Slurry in the Prevention of Uterine Scarring in Patients Undergoing Hysteroscopic Myomectomy [Phase 4]
Summary
Phase 4 trial update on Seprafilm slurry to prevent uterine scarring in hysteroscopic myomectomy; study terminated with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Weill Medical College of Cornell University | Conditions: Intrauterine Adhesions | Phase 4 | Status: TERMINATED | Results posted: 2020-12-03